BACKGROUND: The magnitude of the link between cigarette smoking and lung cancer may vary by histological type. METHODS: We used polytomous logistic regression to evaluate whether aspects of smoking have different effects across four histological types in the Nurses' Health Study. RESULTS: From 1976 to 2002, we identified 1062 cases of lung cancer: squamous cell (n = 201), small cell (n = 236), adenocarcinoma (n = 543) and large cell carcinoma (n = 82), among 65 560 current or former smokers. Risk reduction after quitting ranged from an 8% reduction (relative risk (RR): 0.92, 95% CI 0.91 to 0.94) to a 17% reduction (RR: 0.83, 95% CI 0.80 to 0.86) per year for adenocarcinoma and small cell carcinoma, respectively, with a 9% reduction observed for large cell carcinoma and an 11% reduction observed for squamous cell carcinoma. The association of age at smoking initiation and former cigarette smoking was similar across types, while the association of smoking duration differed. The risk of adenocarcinoma increased by 6% per year of smoking, compared to 7% for large cell, 10% for squamous cell and 12% for small cell. The 6% difference between adenocarcinoma and small cell carcinoma is equivalent to a 3.2 to 9.7-fold increase in risk for 20 years of smoking. CONCLUSIONS: The effects of the number of cigarettes smoked per day and years since quitting smoking are different across the major types of lung cancer, which are fully appreciated at long durations of smoking and smoking cessation. Smoking prevention and cessation should continue to be the focus of public health efforts to reduce lung cancer incidence and mortality.
BACKGROUND: The magnitude of the link between cigarette smoking and lung cancer may vary by histological type. METHODS: We used polytomous logistic regression to evaluate whether aspects of smoking have different effects across four histological types in the Nurses' Health Study. RESULTS: From 1976 to 2002, we identified 1062 cases of lung cancer: squamous cell (n = 201), small cell (n = 236), adenocarcinoma (n = 543) and large cell carcinoma (n = 82), among 65 560 current or former smokers. Risk reduction after quitting ranged from an 8% reduction (relative risk (RR): 0.92, 95% CI 0.91 to 0.94) to a 17% reduction (RR: 0.83, 95% CI 0.80 to 0.86) per year for adenocarcinoma and small cell carcinoma, respectively, with a 9% reduction observed for large cell carcinoma and an 11% reduction observed for squamous cell carcinoma. The association of age at smoking initiation and former cigarette smoking was similar across types, while the association of smoking duration differed. The risk of adenocarcinoma increased by 6% per year of smoking, compared to 7% for large cell, 10% for squamous cell and 12% for small cell. The 6% difference between adenocarcinoma and small cell carcinoma is equivalent to a 3.2 to 9.7-fold increase in risk for 20 years of smoking. CONCLUSIONS: The effects of the number of cigarettes smoked per day and years since quitting smoking are different across the major types of lung cancer, which are fully appreciated at long durations of smoking and smoking cessation. Smoking prevention and cessation should continue to be the focus of public health efforts to reduce lung cancer incidence and mortality.
Authors: R W Field; B J Smith; C E Platz; R A Robinson; J S Neuberger; C P Brus; C F Lynch Journal: J Natl Cancer Inst Date: 2004-07-21 Impact factor: 13.506
Authors: J O Ebbert; P Yang; C M Vachon; R A Vierkant; J R Cerhan; A R Folsom; T A Sellers Journal: J Clin Oncol Date: 2003-03-01 Impact factor: 44.544
Authors: Chris Bain; Diane Feskanich; Frank E Speizer; Michael Thun; Ellen Hertzmark; Bernard A Rosner; Graham A Colditz Journal: J Natl Cancer Inst Date: 2004-06-02 Impact factor: 13.506
Authors: Ahmedin Jemal; Kimberly D Miller; Jiemin Ma; Rebecca L Siegel; Stacey A Fedewa; Farhad Islami; Susan S Devesa; Michael J Thun Journal: N Engl J Med Date: 2018-05-24 Impact factor: 91.245
Authors: Matthew T Chang; Alexander Penson; Neil B Desai; Nicholas D Socci; Ronglai Shen; Venkatraman E Seshan; Ritika Kundra; Adam Abeshouse; Agnes Viale; Eugene K Cha; Xueli Hao; Victor E Reuter; Charles M Rudin; Bernard H Bochner; Jonathan E Rosenberg; Dean F Bajorin; Nikolaus Schultz; Michael F Berger; Gopa Iyer; David B Solit; Hikmat A Al-Ahmadie; Barry S Taylor Journal: Clin Cancer Res Date: 2017-11-27 Impact factor: 12.531
Authors: Youngwook Kim; Peter S Hammerman; Jaegil Kim; Ji-ae Yoon; Yoomi Lee; Jong-Mu Sun; Matthew D Wilkerson; Chandra Sekhar Pedamallu; Kristian Cibulskis; Yeong Kyung Yoo; Michael S Lawrence; Petar Stojanov; Scott L Carter; Aaron McKenna; Chip Stewart; Andrey Y Sivachenko; In-Jae Oh; Hong Kwan Kim; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim; Kyu-Sik Kim; Sang-Yun Song; Kook-Joo Na; Yoon-La Choi; D Neil Hayes; Jhingook Kim; Sukki Cho; Young-Chul Kim; Jin Seok Ahn; Myung-Ju Ahn; Gad Getz; Matthew Meyerson; Keunchil Park Journal: J Clin Oncol Date: 2013-12-09 Impact factor: 44.544
Authors: Caroline A Thompson; Scarlett Lin Gomez; Katherine G Hastings; Kristopher Kapphahn; Peter Yu; Salma Shariff-Marco; Ami S Bhatt; Heather A Wakelee; Manali I Patel; Mark R Cullen; Latha P Palaniappan Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-10 Impact factor: 4.254